CDNA CareDx
- 14.980
- +0.150+1.01%
- 15.265
- +0.285+1.90%
CareDx News
Navigating 5 Analyst Ratings For CareDx
Throughout the last three months, 5 analysts have evaluated CareDx (NASDAQ:CDNA), offering a diverse set of opinions from bullish to bearish.The table below summarizes their recent ratings, showcasing
Raymond James Company: Downgraded the CareDX (CDNA.US) rating from superior to market to consistent market rating.
Raymond James Company: Downgraded the CareDX (CDNA.US) rating from superior to market to consistent market rating.
Raymond James Downgrades CareDx to Market Perform
Raymond James analyst Andrew Cooper downgrades CareDx (NASDAQ:CDNA) from Outperform to Market Perform.
CareDx Cut to Market Perform by Raymond James Over Valuation
CareDx Is Maintained at Overweight by Stephens & Co.
CareDx Is Maintained at Overweight by Stephens & Co.
CareDx Price Target Raised to $18.00/Share From $15.00 by Stephens & Co.
CareDx Price Target Raised to $18.00/Share From $15.00 by Stephens & Co.
Stephens & Co. : Maintaining the CaredX (CDNA.US) rating, adjusted from an increase in holdings to an increase rating, and the target price was adjusted from $15.00 to $18.00.
Stephens & Co. : Maintaining the CaredX (CDNA.US) rating, adjusted from an increase in holdings to an increase rating, and the target price was adjusted from $15.00 to $18.00.
Stephens & Co. Maintains Overweight on CareDx, Raises Price Target to $18
Stephens & Co. analyst Mason Carrico maintains CareDx with a Overweight and raises the price target from $15 to $18.
CareDx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 18.42% Stephens & Co. $15 → $18 Maintains Overweight 05/09/2024 -1.32% Craig-Hallum → $15 Reite
CareDx, Inc (NASDAQ:CDNA) Surges 62% Yet Its Low P/S Is No Reason For Excitement
CareDx, Inc (NASDAQ:CDNA) shareholders have had their patience rewarded with a 62% share price jump in the last month. Looking back a bit further, it's encouraging to see the stock is up 84% in the
Earnings Update: Here's Why Analysts Just Lifted Their CareDx, Inc (NASDAQ:CDNA) Price Target To US$13.80
Sector Update: Health Care Stocks Higher Late Afternoon
Health care stocks rose late Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each increasing 0.3%. The iShares Biotechnology ETF (IBB) added 0.1%. In
CareDx Reports Mixed Q1 2024 Results; Raises Annual Revenue Guidance
CareDx Rises as Much as 38%, Highest Intraday Gain in Six Years
NVAX, GRPN and MVIS Among Mid-day Movers
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Diodes posted adjusted earnings of 28 cents
CareDx Shares Hit 52-Week High After Narrower-Than-Expected 1Q Loss
By Chris Wack CareDx shares hit their 52-week high of $15.30 after the company reported a first-quarter loss that was narrower than analysts' expectations. The stock is trading 30% higher at $14.42
CareDx Up Over 30%, on Pace for Largest Percent Increase Since October 2017 -- Data Talk
CareDx, Inc. (CDNA) is currently at $14.43, up $3.37 or 30.51% --Would be highest close since March 1, 2023, when it closed at $16.00 --On pace for largest percent increase since Oct. 5, 2017, when
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
U.S. stocks were mostly higher, with the Dow Jones gaining over 100 points on Friday.
Earnings Call Summary | CareDx(CDNA.US) Q1 2024 Earnings Conference
The following is a summary of the CareDx, Inc. (CDNA) Q1 2024 Earnings Call Transcript:Financial Performance:CareDx reported Q1 revenue of $72 million, up 10% from the prior quarter.The revenue from T
Analysis
Price Target
No Data
